- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions
European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine disulphate salt
| EU orphan designation number: | EU/3/15/1446
|
| Active ingredient: | N-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1H-benzo[d]imidazol-2-amine disulphate salt |
| Indication: | Treatment of progressive supranuclear palsy |
| Sponsor: | AlzProtect sas
70 rue du Docteur Alexandre Yersin, 59120 Loos, France |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 16/02/2015 | Orphan designation | EMA/OD/261/14 | (2015)951 of 12/02/2015 |
CONTACT
EU links
Directorate General Health & Consumers